N-alkyl-azacycloalkyl nmda/nr2b antagonists

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/04 (2006.01) A61K 31/519 (2006.01) A61P 25/00 (2006.01) A61P 31/18 (2006.01) C07D 519/00 (2006.01)

Patent

CA 2603876

Compounds represented by Formula (I): and/or pharmaceutically acceptable salts, individual enantiomers and stereoisomers thereof, are effective as NMDA/NR2B antagonists useful for treating conditions such as pain, Parkinson~s disease, Alzheimer~s disease, epilepsy, depression, anxiety, ischemic brain injury including stroke.

La présente invention concerne des composés représentés par la formule (I) et/ou des sels, des énantiomères individuels et des stéréoisomères de ceux-ci, acceptables d'un point de vue pharmaceutique, qui sont efficaces comme antagonistes de NMDA/NR2B, utilisés pour traiter des pathologies comme la douleur, la maladie de Parkinson, la maladie d'Alzheimer, l'épilepsie, la dépression, l'anxiété et les lésions cérébrales d'origine ischémique, par exemple l'accident vasculaire cérébral.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

N-alkyl-azacycloalkyl nmda/nr2b antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-alkyl-azacycloalkyl nmda/nr2b antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-alkyl-azacycloalkyl nmda/nr2b antagonists will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1806057

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.